These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15503374)

  • 1. MultiHance-enhanced MRI in the characterisation of focal liver lesions.
    Leen E
    Eur Radiol; 2004 Jun; 14 Suppl 7():O31-5; discussion O41-2. PubMed ID: 15503374
    [No Abstract]   [Full Text] [Related]  

  • 2. MultiHance in liver lesion detection: personal experience.
    Grazioli L
    Eur Radiol; 2004 Jun; 14 Suppl 7():O25-30; discussion O41-2. PubMed ID: 15503373
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose gadobenate dimeglumine-enhanced MRI in the detection and characterization of focal liver lesions.
    Kirchin MA; Spinazzi A
    Acad Radiol; 2002 May; 9 Suppl 1():S121-6. PubMed ID: 12019846
    [No Abstract]   [Full Text] [Related]  

  • 4. MultiHance and state-of-the-art contrast-enhanced MRI.
    Spinazzi A
    Eur Radiol; 2004 Jun; 14 Suppl 7():O87-8. PubMed ID: 15503382
    [No Abstract]   [Full Text] [Related]  

  • 5. MultiHance: help or hype?
    Bartolozzi C; Spinazzi A
    J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S151-9. PubMed ID: 10608411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment.
    Grazioli L; Kirchin M; Pirovano G; Spinazzi A
    J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S61-4. PubMed ID: 10608399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver lesion characterization: the wrong choice of contrast agent can mislead the diagnosis of hemangioma.
    Pradella S; Lucarini S; Colagrande S
    AJR Am J Roentgenol; 2012 Nov; 199(5):W662. PubMed ID: 23096214
    [No Abstract]   [Full Text] [Related]  

  • 8. Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media.
    Marin D; Brancatelli G; Federle MP; Lagalla R; Catalano C; Passariello R; Midiri M; Vilgrain V
    Clin Radiol; 2008 May; 63(5):577-85. PubMed ID: 18374723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility and safety of MultiHance in magnetic resonance imaging of liver cancer: results of multicenter studies in Europe and the USA.
    Hamm B; Kirchin M; Pirovano G; Spinazzi A
    J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S53-60. PubMed ID: 10608398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MultiHance in brain tumor imaging.
    Jansen O
    Eur Radiol; 2004 Jun; 14 Suppl 7():O5-9; discussion O20-1. PubMed ID: 15503370
    [No Abstract]   [Full Text] [Related]  

  • 11. MultiHance in cardiac magnetic resonance imaging.
    Schneider G; Saedi D; Massmann A; Fries P; Boehm M; Kramann B; Winter H
    Eur Radiol; 2004 Jun; 14 Suppl 7():O71-9; discussion O84-5. PubMed ID: 15503380
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatocyte-specific magnetic resonance imaging contrast agents.
    Fidler J; Hough D
    Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicenter testing of gadobenate dimeglumine in magnetic resonance imaging of focal liver disease.
    Spinazzi A; Pirovano G; Ratcliffe G; Pezzoli C; Rosati G
    Acad Radiol; 1996 Aug; 3 Suppl 2():S415-6. PubMed ID: 8796618
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
    Fowler KJ; Brown JJ; Narra VR
    Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MultiHance for dynamic MR imaging of the breast.
    Sardanelli F
    Eur Radiol; 2004 Jun; 14 Suppl 7():O65-70; discussion O84-5. PubMed ID: 15503379
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypervascular hepatic lesions: dynamic and late enhancement pattern with Gd-BOPTA.
    Morana G; Grazioli L; Schneider G; Testoni M; Menni K; Chiesa A; Procacci C
    Acad Radiol; 2002 Aug; 9 Suppl 2():S476-9. PubMed ID: 12188313
    [No Abstract]   [Full Text] [Related]  

  • 17. Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration.
    Morana G; Grazioli L; Kirchin MA; Bondioni MP; Faccioli N; Guarise A; Schneider G
    Invest Radiol; 2011 Apr; 46(4):225-39. PubMed ID: 21102346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MultiHance in multiple sclerosis: update of a study in progress.
    Tartaro A
    Eur Radiol; 2004 Jun; 14 Suppl 7():O16-9; discussion O20-1. PubMed ID: 15503372
    [No Abstract]   [Full Text] [Related]  

  • 19. Gadobenate dimeglumine-enhanced liver magnetic resonance imaging: value of hepatobiliary phase for the detection of focal liver lesions.
    Fu GL; Du Y; Zee CS; Yang HF; Li Y; Duan RG; Zeng NL; Xiao DM
    J Comput Assist Tomogr; 2012; 36(1):14-9. PubMed ID: 22261765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MultiHance in brain perfusion.
    Essig M
    Eur Radiol; 2004 Jun; 14 Suppl 7():O10-5; discussion O20-1. PubMed ID: 15503371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.